Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards.

Source:http://linkedlifedata.com/resource/pubmed/id/9731509

Cancer Res. 1998 Sep 1 58 17 3957-64

Download in:

View as

General Info

PMID
9731509